More articles from Clinical Studies

You have access
Prognostic Role of Lung Immune Scores for Prediction of Survival in Limited-stage Small Cell Lung Cancer
LEON SCHNÖLLER, LUKAS KÄSMANN, JULIAN TAUGNER, REEM ABDO, CHUKWUKA EZE and FARKHAD MANAPOV

In Vivo March 2021, 35 (2) 929-935; DOI: https://doi.org/10.21873/invivo.12333
You have access
Outcome After Radiation Therapy in Canine Intracranial Meningiomas or Gliomas
TOMÁS RODRIGUES MAGALHÃES, JÉRÔME BENOÎT, SLAVOMÍRA NÉČOVÁ, SUSAN NORTH and FELISBINA LUÍSA QUEIROGA

In Vivo March 2021, 35 (2) 1117-1123; DOI: https://doi.org/10.21873/invivo.12357
You have access
Perineural Invasion Correlates With Common Pathological Variables and Clinical Outcomes of Patients With Squamous Cell Carcinoma of the Vulva Treated With Primary Radical Surgery and Inguinal-femoral Lymphadenectomy
ANGIOLO GADDUCCI, SABINA PISTOLESI, STEFANIA COSIO, CHIARA COMUNALE, ANTONIO FANUCCHI and ANTONIO GIUSEPPE NACCARATO

In Vivo March 2021, 35 (2) 1051-1056; DOI: https://doi.org/10.21873/invivo.12349
You have access
Cytotoxic T-lymphocyte Antigen-4 (CTLA-4) Gene Polymorphism (rs3087243) Is Related to Risk and Survival in Patients With Colorectal Cancer
SONG VAN NGUYEN, LEVAR SHAMOUN, KALLE LANDERHOLM, ROLAND E. ANDERSSON, DICK WAGSATER and JAN DIMBERG

In Vivo March 2021, 35 (2) 969-975; DOI: https://doi.org/10.21873/invivo.12339
You have access
Homozygosity for rs17775810 Minor Allele Associated With Reduced Mortality of COVID-19 in the UK Biobank Cohort
STEVEN LEHRER and PETER H. RHEINSTEIN

In Vivo March 2021, 35 (2) 965-968; DOI: https://doi.org/10.21873/invivo.12338
You have access
Neutrophil-to-Lymphocyte Ratio After Definitive Concurrent Chemoradiotherapy Predicts Survival in Patients With Esophageal Squamous Cell Carcinoma
HYEON KANG KOH, YOUNGHEE PARK, TAERYOOL KOO, HAE JIN PARK, ME YEON LEE, AH RAM CHANG, SEMIE HONG and HOONSIK BAE

In Vivo March 2021, 35 (2) 1133-1139; DOI: https://doi.org/10.21873/invivo.12359
You have access
Comparison of Central Venous Port Procedures Between Puncture vs. Cut-down and Residents vs. Senior Surgeons
RYOTA OTSUBO, HIROSHI YANO, MEGUMI MATSUMOTO, AYA TANAKA, TAKASHI NONAKA, SHIGEKAZU HIDAKA, KEITARO MATSUMOTO, TOMOSHI TSUCHIYA, SHUNTARO SATO and TAKESHI NAGAYASU

In Vivo March 2021, 35 (2) 1197-1204; DOI: https://doi.org/10.21873/invivo.12369
You have access
Effectiveness of Vintage Hormone Therapy as Alternative Androgen Deprivation Therapy for Non-metastatic Castration-resistant Prostate Cancer
HIROAKI IWAMOTO, HIROSHI KANO, TAKAFUMI SHIMADA, RENATO NAITO, TOMOYUKI MAKINO, SUGURU KADAMOTO, HIROSHI YAEGASHI, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, YOSHIFUMI KADONOA and ATSUSHI MIZOKAMI

In Vivo March 2021, 35 (2) 1247-1252; DOI: https://doi.org/10.21873/invivo.12375
You have access
A Finnish Version of RAND-36-Item Health Survey Versus Structured Interview 8 Years Postoperatively
IINA SAIMANEN, VIIVI KUOSMANEN, JUKKA HARJU, TUOMAS SELANDER, SAMULI ASPINEN and MATTI ESKELINEN

In Vivo March 2021, 35 (2) 907-911; DOI: https://doi.org/10.21873/invivo.12330
You have access
Diagnostic Utility of Oncomine Comprehensive Assay v3 in Differentiating Between Isocitrate Dehydrogenase (IDH)-mutated Grade II-III Astrocytoma and Oligodendroglioma
SO-WOON KIM, BONG JIN PARK, HYUN-SOO KIM and KIYONG NA

In Vivo March 2021, 35 (2) 921-927; DOI: https://doi.org/10.21873/invivo.12332

Main menu

User menu

Search

More articles from Clinical Studies

Pages